The KEGG pathway analysis highlighted the “PD-L1 expression and PD-1 checkpoint pathway in cancer,” which, despite its primary focus on oncological contexts, sheds light on the immunological alterations occurring in CHD. This evidence concerns the gene CD274 and cancer.